Compare VYGR & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VYGR | SPCE |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 226.8M | 207.3M |
| IPO Year | 2015 | N/A |
| Metric | VYGR | SPCE |
|---|---|---|
| Price | $4.02 | $3.20 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 6 |
| Target Price | ★ $17.00 | $9.22 |
| AVG Volume (30 Days) | 375.7K | ★ 5.6M |
| Earning Date | 11-10-2025 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $31,316,000.00 | $1,661,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $71.78 | $2,656.89 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.65 | $2.18 |
| 52 Week High | $5.96 | $6.64 |
| Indicator | VYGR | SPCE |
|---|---|---|
| Relative Strength Index (RSI) | 46.28 | 43.28 |
| Support Level | $3.89 | $3.11 |
| Resistance Level | $4.19 | $3.37 |
| Average True Range (ATR) | 0.19 | 0.23 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 50.57 | 11.40 |
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.